Eterna Therapeutics
ERNA
#11171
Rank
A$3.47 M
Marketcap
A$2.05
Share price
-16.56%
Change (1 day)
-4.24%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): A-$43.73

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is A-$44.17. In 2022 the company made an earnings per share (EPS) of A-$4,745 an increase over its 2021 EPS that were of A-$31,346.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$43.73
2022A-$4,745-84.86%
2021A-$31,346

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.99-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$2.13-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A$2.58-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.12-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$0.68-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$1.76-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA